A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
Condition(s):Diarrhea-Associated Hemolytic Uremic Syndrome; Pediatric Kidney Disease; Hemolytic-Uremic SyndromeLast Updated:August 21, 2023Completed